<div id="secondary-menu" class="nav-mega-wrapper sub-menu" >
        <nav class="nav-mega" itemscope="itemscope" itemtype="http://schema.org/SiteNavigationElement">
            <a href="#" id="cosentyx-logo">
                <img itemprop="logo" class="logo" src="/siteassets/hcp-portal-master/medicines/cosentyx/img/cosentyxlogo.svg" alt="ServiceSphere GB">
            </a>
            <a href="#" class="nav-mega-link " itemprop="name" id="sec-menu0">Home</a>
            <a href="#" class="nav-mega-link " itemprop="name" id="sec-menu1">Early<br>Intervention</a>
            <a href="#" class="nav-mega-link " itemprop="name" id="sec-menu2">Targeting<br>Inflammation</a>
            <a href="#" class="nav-mega-link " itemprop="name" id="sec-menu2">Ankylosing<br>Spondylitis</a>
            <a href="#" class="nav-mega-link " itemprop="name" id="sec-menu2">Psoriatic<br>Arthritis</a>
            <a href="#" class="nav-mega-link " itemprop="name" id="sec-menu2">Mission for<br>movement</a>
            <a href="#" class="nav-mega-link " itemprop="name" id="sec-menu2">Resources</a>
            <a href="#" class="nav-mega-link " itemprop="name" id="sec-menu2">Contact Us</a>
            <a href="#" class="nav-mega-link " itemprop="name" id="sec-menu2">Prescribing<br>Information</a>
    </nav>
</div>
<div class="text--block">
<p class="cos-abv">AS: ankylosing spondylitis; DMARD: Disease-modifying anti-rheumatic drug; IL: interleukin; PsA: psoriatic arthritis; PsO: psoriasis; RA: rheumatoid arthritis; Th<sup>17</sup>: T helper 17; TNF-α: tumour necrosis factor alpha</p>
<p class="cos-references"><b>References</b><br /> <strong>1.</strong> Miossec P, Kolls JK. <em>Nat Rev Drug Discov</em> 2012; 11:763–776. <strong>2.</strong> Lories RJ, McInnes IB. Nat Med 2012; 18:1018–1019. <strong>3.</strong> Sherlock JP <em>et al. Nat Med</em> 2012; 18:1069–1076. <strong>4.</strong> Kehl AS <em>et al. Arthritis Rheumatol</em> 2016; 68:312–322. <strong>5.</strong> Ritchlin CT <em>et al. N Engl J Med</em> 2017; 376:957–970. <strong>6.</strong> van Tok M <em>et al. Arthritis Rheumatol</em> 2015; 67(Suppl 10):Abstract 981. <strong>7.</strong> Smith JA, Colbert RA. <em>Arthritis Rheumatol</em> 2014; 66:231–241. <strong>8.</strong> Baeten D <em>et al. Arthritis Rheumatol</em> 2013; 65:12–20. <strong>9.</strong> Lubberts E <em>et al. Nat Rev Rheumatol</em> 2015; 11:415–429. <strong>10.</strong> McGonagle D, Benjamin M. <em>Topical Reviews</em> 2009; 4:1–6. <strong>11.</strong> Masi AT <em>et al. Arthritis</em> 2011; 2011:205904. <strong>12.</strong> Baeten D <em>et al. N Engl J Med</em> 2015; 373:2534–2548. <strong>13.</strong> Cua DJ <em>et al. Nat Rev Immunol</em> 2010; 10:479–489. <strong>14.</strong> Appel H <em>et al. Arthritis Res Ther</em> 2011; 13:R95. <strong>15.</strong> McGonagle D <em>et al. Nat Rev Rheumatol</em> 2015; 11:731–740. <strong>16.</strong> Mease PJ <em>et al. Arthritis Care Res (Hoboken)</em> 2017; 69(11):1692-1699. <strong>17.</strong> McGonagle D <em>et al. Arthritis Rheum</em> 2007; 56:2482–2491. <strong>18.</strong> Mease PJ <em>et al. N Engl J Med</em> 2015; 373:1329–1339. <strong>19.</strong> McInnes IB <em>et al. Lancet</em> 2015; 386:1137–1146. <strong>20.</strong> Zeichner JA <em>et al. J Clin Aesthet Dermatol</em> 2016; 9:S3-6. <strong>21.</strong> Lynde CW <em>et al. J Am Acad dermatol</em> 2014; 71:141–150. <strong>22.</strong> Keijsers RR <em>et al. Exp Dermatol</em> 2014; 23(11):799–803. <strong>23.</strong> Cosentyx SmPC 2017. <strong>24.</strong> Hochberg MC <em>et al. Rheumatology</em> 2015. 6th edition. Philadelphia, PA: Elsevier. <strong>25.</strong> Schett G <em>et al. Arthritis Res Ther</em> 2011;13(Suppl 1): S4.</p>
</div>
